Lipemic serum in patients with Coronavirus Disease 2019 (COVID‐19) undergoing treatment
2020; Wiley; Volume: 92; Issue: 10 Linguagem: Inglês
10.1002/jmv.25942
ISSN1096-9071
AutoresAbdur Rahman Rubel, Pui Lin Chong, Muhammad Syafiq Abdullah, Rosmonaliza Asli, Riamiza Natalie Momin, Babu Ivan Mani, Vui Heng Chong,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoJournal of Medical VirologyVolume 92, Issue 10 p. 1810-1811 LETTER TO THE EDITOR Lipemic serum in patients with Coronavirus Disease 2019 (COVID-19) undergoing treatment Abdur Rahman Rubel, Abdur Rahman Rubel Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei DarussalamSearch for more papers by this authorPui Lin Chong, Pui Lin Chong Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorMuhammad Syafiq Abdullah, Muhammad Syafiq Abdullah Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam Institute of Health Science, PAPRSB, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorRosmonaliza Asli, Rosmonaliza Asli Infectious Disease Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorRiamiza Natalie Momin, Riamiza Natalie Momin Infectious Disease Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorBabu Ivan Mani, Babu Ivan Mani Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei DarussalamSearch for more papers by this authorVui Heng Chong, Corresponding Author Vui Heng Chong [email protected] orcid.org/0000-0002-2844-4872 Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei Darussalam Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam Institute of Health Science, PAPRSB, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam Correspondence Vui Heng Chong, Department of Internal Medicine, PMMPMHAMB Hospital, Jalan Sungai Basong, Tutong 1341, Brunei Darussalam. Email: [email protected]Search for more papers by this author Abdur Rahman Rubel, Abdur Rahman Rubel Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei DarussalamSearch for more papers by this authorPui Lin Chong, Pui Lin Chong Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorMuhammad Syafiq Abdullah, Muhammad Syafiq Abdullah Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam Institute of Health Science, PAPRSB, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorRosmonaliza Asli, Rosmonaliza Asli Infectious Disease Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorRiamiza Natalie Momin, Riamiza Natalie Momin Infectious Disease Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei DarussalamSearch for more papers by this authorBabu Ivan Mani, Babu Ivan Mani Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei DarussalamSearch for more papers by this authorVui Heng Chong, Corresponding Author Vui Heng Chong [email protected] orcid.org/0000-0002-2844-4872 Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei Darussalam Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam Institute of Health Science, PAPRSB, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam Correspondence Vui Heng Chong, Department of Internal Medicine, PMMPMHAMB Hospital, Jalan Sungai Basong, Tutong 1341, Brunei Darussalam. Email: [email protected]Search for more papers by this author First published: 28 April 2020 https://doi.org/10.1002/jmv.25942Citations: 12Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Morrison AR, Johnson JM, Ramesh M, Bradley P, Jennings J, Smith ZR. Letter to the Editor: acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab. J Med Virol, 2020. https://doi.org/10.1002/jmv.25907 10.1002/jmv.25907 Google Scholar 2Matoga MM, Hosseinipour MC, Aga E, et al. Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings. Antivir Ther. 2017; 22(3): 205-213. 10.3851/IMP3101 CASPubMedWeb of Science®Google Scholar 3Montes ML, Pulido F, Barros C, et al. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization, and risk factors. J Antimicrob Chemother. 2005; 55: 800-804. 10.1093/jac/dki063 CASPubMedWeb of Science®Google Scholar Citing Literature Volume92, Issue10Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VIOctober 2020Pages 1810-1811 ReferencesRelatedInformation
Referência(s)